SCHEMBL3000588

SCHEMBL3000588

COC(=O)c1ccc(C(c2ccc(CCc3ccccn3)cc2)C(C)(C)C)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.48
ALDH1A1 P00352 3/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
IDH1 O75874 1/20 0.43
KDM4E B2RXH2 3/20 0.43
MAPT P10636 2/20 0.43
POLB P06746 1/20 0.43
CYP1A2 P05177 1/20 0.43
RGS12 O14924 1/20 0.42
HPGD P15428 1/20 0.42
CYP4A11 Q02928 2/20 0.42
CYP4F2 P78329 1/20 0.41
METAP2 P50579 1/20 0.41
PGR P06401 1/20 0.41
ADORA3 P0DMS8 1/20 0.41
PTGS1 P23219 1/20 0.41
SLC6A2 P23975 1/20 0.41
AGTR1 P30556 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL509956 0.88 PKM (0.59) PKMALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL12356701 0.84 PARP10 (0.55) PKMALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL2250280 0.84 PARP10 (0.55) PKMALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL14642565 0.79 TRPV1 (0.50) PKMALDH1A1SMN1; SMN2KDM4EMAPT
SCHEMBL13268171 0.79 ALDH1A1 (0.46) ALDH1A1MEN1KMT2ASMN1; SMN2KDM4E
SCHEMBL7834117 0.76 PKM (0.60) PKMALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL2993518 0.75 FFAR1 (0.44) PKMALDH1A1SMN1; SMN2KDM4EMAPT
SCHEMBL6019287 0.75 ALOX15 (0.60) PKMALDH1A1MEN1KMT2AKDM4E
SCHEMBL4923114 0.75 PKM (0.53) PKMALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL480272 0.75 PARP10 (0.49) ALDH1A1MEN1KMT2ASMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2546232-A1 Diphenyl Substituted Alkanes Merck Sharp & Dohme Corp. (US) 2013-01-16 EP disclosed
EP-2546232-A1 Diphenyl Substituted Alkanes Merck Sharp & Dohme Corp. (US) 2013-01-16 EP disclosed
US-20100190761-A1 DIPHENYL SUBSTITUTED ALKANES MERCK SHARP & DOHME CORP. 2010-07-29 US disclosed
US-20100190761-A1 DIPHENYL SUBSTITUTED ALKANES MERCK SHARP & DOHME CORP. 2010-07-29 US disclosed
WO-2008156721-A1 DIPHENYL SUBSTITUTED ALKANES MERCK & CO., INC. (US) 2008-12-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100190761-A1 DIPHENYL SUBSTITUTED ALKANES ALOX5, ALOX15, ALOX15B PKM 3033/4885ALDH1A1 159/4885MEN1 4664/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.